CNBC Investment Club Trims Position After 46 Weekly Gain and 80 Surge Since April Healthcare Revolution How Technology is Transforming Medicine with Sensors 3D Printing and Wearables Snowflake Surges After Earnings Beat and 6 Billion Amazon Cloud Deal SpaceX Delays Starship Flight 12 to Friday Debuting V3 Rocket with Enhanced Capacity Mixed Session as Consumer Stocks Prop Up SP 500 Tech and Energy Falter Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes CHH Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction SCCO Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience BRX Q1 2026 Earnings Strong EPS Surprise of 635 Despite Slight Stock Decline OCCIO Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment SERV Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty Simply Good Foods SMPL Gains 224 as Shares Test Resistance Near 1245 Scilex Holding Company Warrant SCLXW Slides 14 as Momentum Falters Near Support Japer Therapeutics Warrants JSPRW Flat at Penny Level Amid Minimal Activity Skyline Builders Group Holding Limited SKBL Struggles Near Support as Selling Pressure Intensifies Coffee Holding Co JVA Brews Upward Momentum 206 Surge Challenges Resistance World Bank Data Suggests Automation Could Threaten 69 of Jobs in India National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Edges Higher Amid Limited Disclosures Petrobras PBR Slips 269 as Oil Sector Headwinds Pressure Shares YDKG Q4 2012 Earnings EPS Misses Estimates by 1422 as Stock Gains 458 Alta Equipment Group Inc ALTG Q1 2026 Earnings EPS Miss Highlights Margin Pressure Amid Mixed Demand ARLO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher Bloomin Brands BLMN Q1 2026 Earnings EPS Surprise Lifts Shares Amid Strong Profitability CWD Q1 2026 Earnings Major EPS Miss Highlights Operational Difficulties Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress